DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis
BIT:CPR - NL0015435975 - Common Stock
6.12 EUR
+0.01 (+0.1%)
Overall CPR gets a fundamental rating of 3 out of 10. We evaluated CPR against 25 industry peers in the Beverages industry. CPR has only an average score on both its financial health and profitability. CPR is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CPR was profitable.
In the past year CPR had a positive cash flow from operations.
CPR had positive earnings in each of the past 5 years.
In the past 5 years CPR always reported a positive cash flow from operatings.
1.2 Ratios
CPR's Return On Assets of 2.38% is on the low side compared to the rest of the industry. CPR is outperformed by 68.00% of its industry peers.
Looking at the Return On Equity, with a value of 5.23%, CPR is doing worse than 76.00% of the companies in the same industry.
CPR has a Return On Invested Capital of 6.63%. This is comparable to the rest of the industry: CPR outperforms 52.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CPR is in line with the industry average of 7.82%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.38% | ||
| ROE | 5.23% | ||
| ROIC | 6.63% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
1.3 Margins
The Profit Margin of CPR (6.57%) is worse than 60.00% of its industry peers.
In the last couple of years the Profit Margin of CPR has declined.
The Operating Margin of CPR (21.32%) is comparable to the rest of the industry.
CPR's Operating Margin has been stable in the last couple of years.
CPR has a better Gross Margin (57.55%) than 72.00% of its industry peers.
In the last couple of years the Gross Margin of CPR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% |
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CPR is still creating some value.
Compared to 1 year ago, CPR has more shares outstanding
CPR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CPR has about the same debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.47 indicates that CPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.47, CPR is in the better half of the industry, outperforming 68.00% of the companies in the same industry.
The Debt to FCF ratio of CPR is 13.61, which is on the high side as it means it would take CPR, 13.61 years of fcf income to pay off all of its debts.
CPR has a worse Debt to FCF ratio (13.61) than 64.00% of its industry peers.
CPR has a Debt/Equity ratio of 0.66. This is a neutral value indicating CPR is somewhat dependend on debt financing.
CPR's Debt to Equity ratio of 0.66 is fine compared to the rest of the industry. CPR outperforms 68.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 13.61 | ||
| Altman-Z | 2.47 |
ROIC/WACC0.98
WACC6.76%
2.3 Liquidity
CPR has a Current Ratio of 2.37. This indicates that CPR is financially healthy and has no problem in meeting its short term obligations.
CPR has a Current ratio of 2.37. This is amongst the best in the industry. CPR outperforms 84.00% of its industry peers.
CPR has a Quick Ratio of 2.37. This is a bad value and indicates that CPR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.99, CPR belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
The earnings per share for CPR have decreased strongly by -40.50% in the last year.
The Earnings Per Share has been decreasing by -8.12% on average over the past years.
The Revenue has been growing slightly by 5.18% in the past year.
Measured over the past years, CPR shows a quite strong growth in Revenue. The Revenue has been growing by 10.75% on average per year.
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%N/A
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%N/A
3.2 Future
CPR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.30% yearly.
CPR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.78% yearly.
EPS Next Y-0.58%
EPS Next 2Y4.32%
EPS Next 3Y6.88%
EPS Next 5Y11.3%
Revenue Next Year2.82%
Revenue Next 2Y3.08%
Revenue Next 3Y3.99%
Revenue Next 5Y4.78%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 36.00, CPR can be considered very expensive at the moment.
80.00% of the companies in the same industry are cheaper than CPR, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.03. CPR is valued slightly more expensive when compared to this.
A Price/Forward Earnings ratio of 18.94 indicates a rather expensive valuation of CPR.
Based on the Price/Forward Earnings ratio, CPR is valued a bit more expensive than the industry average as 64.00% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.63, CPR is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36 | ||
| Fwd PE | 18.94 |
4.2 Price Multiples
64.00% of the companies in the same industry are cheaper than CPR, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CPR is valued a bit more expensive than 64.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.81 | ||
| EV/EBITDA | 13.24 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.32%
EPS Next 3Y6.88%
5. Dividend
5.1 Amount
With a yearly dividend of 0.99%, CPR is not a good candidate for dividend investing.
With a Dividend Yield of 0.99, CPR pays less dividend than the industry average, which is at 2.76. 88.00% of the companies listed in the same industry pay a better dividend than CPR!
Compared to an average S&P500 Dividend Yield of 2.32, CPR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.99% |
5.2 History
The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CPR pays out 38.74% of its income as dividend. This is a sustainable payout ratio.
DP38.74%
EPS Next 2Y4.32%
EPS Next 3Y6.88%
BIT:CPR (9/5/2025, 5:35:15 PM)
6.12
+0.01 (+0.1%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst Owners21.06%
Inst Owner ChangeN/A
Ins Owners52%
Ins Owner ChangeN/A
Market Cap7.54B
Analysts70.4
Price Target7.03 (14.87%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.99% |
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.74%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.71%
PT rev (3m)-0.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.87%
EPS NY rev (3m)-1.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36 | ||
| Fwd PE | 18.94 | ||
| P/S | 2.45 | ||
| P/FCF | 35.81 | ||
| P/OCF | 11.24 | ||
| P/B | 1.96 | ||
| P/tB | 165.25 | ||
| EV/EBITDA | 13.24 |
EPS(TTM)0.17
EY2.78%
EPS(NY)0.32
Fwd EY5.28%
FCF(TTM)0.17
FCFY2.79%
OCF(TTM)0.54
OCFY8.9%
SpS2.49
BVpS3.13
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.38% | ||
| ROE | 5.23% | ||
| ROCE | 9.04% | ||
| ROIC | 6.63% | ||
| ROICexc | 6.65% | ||
| ROICexgc | 14.09% | ||
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% | ||
| FCFM | 6.85% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexcg growth 3Y-20.45%
ROICexcg growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score4
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 13.61 | ||
| Debt/EBITDA | 3.27 | ||
| Cap/Depr | 360.3% | ||
| Cap/Sales | 14.99% | ||
| Interest Coverage | 6.99 | ||
| Cash Conversion | 85.71% | ||
| Profit Quality | 104.37% | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | 2.47 |
F-Score4
WACC6.76%
ROIC/WACC0.98
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%N/A
EPS Next Y-0.58%
EPS Next 2Y4.32%
EPS Next 3Y6.88%
EPS Next 5Y11.3%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%N/A
Revenue Next Year2.82%
Revenue Next 2Y3.08%
Revenue Next 3Y3.99%
Revenue Next 5Y4.78%
EBIT growth 1Y6.42%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year23.05%
EBIT Next 3Y13.08%
EBIT Next 5Y10.58%
FCF growth 1Y232.49%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y328.44%
OCF growth 3Y11.5%
OCF growth 5Y13.06%